An Open, Controlled Study of Two Non-absorbable Antibiotics for the Oral Treatment of Paediatric Infectious Diarrhoea
- 1 January 1997
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 14 (1) , 39-45
- https://doi.org/10.1185/03007999709113341
Abstract
SummaryForty-nine children in need of antibacterial treatment for a severe episode of bacterial diarrhoea were consecutively treated with either an oral paediatric suspension of rifaximin (100 mg every six hours for an average of four days: 24 patients), or paromomycin (125 mg every six hours for an average of four days: 25 patients). Stools (number and form), enteritis symptoms and signs, and intolerance manifestations were all monitored on each day of treatment. A stool culture was performed on the first available stool after enrolment and after the end of treatment to monitor the drugs' antibacterial activity.A similar rate of bacteriological cure, with normalisation of stools and elimination of the clinical symptomatology, was attained by the two antibiotics, with statistical significance of changes vs. baseline being apparent on the second treatment day, in both treatment groups. Rifaximin results were quicker (treatment lasted three days in several cases) and on the whole slightly better (though wit...Keywords
This publication has 11 references indexed in Scilit:
- Endogenous endophthalmitis due to Streptococcus agalactiae: case report and revieClinical Microbiology & Infection, 1996
- RifaximinDrugs, 1995
- Rifaximin in the treatment of chronic hepatic encephalopathy; results of a multicenter study of efficacy and safetyCurrent Therapeutic Research, 1993
- Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivativeDiagnostic Microbiology and Infectious Disease, 1993
- Double-blind, double-dummy comparison between treatment andwith rifaximin and lactulose in patients with medium to severe patients with medium to severeCurrent Medical Research and Opinion, 1993
- Evaluation of New Anti-Infective Drugs for the Treatment of Acute Infectious DiarrheaClinical Infectious Diseases, 1992
- Effect of rifaximin and paromomycin in the treatment of portal-systemic encephalopathyCurrent Therapeutic Research, 1992
- Management of gastroenteritis.Archives of Disease in Childhood, 1990
- Treatment of Small Intestine Bacterial Overgrowth with Rifaximin, a Non-Absorbable RifamycinJournal of International Medical Research, 1988
- Rifaximin, a Rifamycin Derivative for Use in the Treatment of Intestinal Bacterial Infections in Seriously Disabled PatientsJournal of International Medical Research, 1987